Wenxia Bai
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Wenxia Bai has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
Fei Xia
Nanjing Med Univ, Dept Gastroenterol, Affiliated Jiangning Hosp, Nanjing 211100, Peoples R China
2 shared publicationsLin Fang
Nanjing Med Univ, Dept Gastroenterol, Affiliated Jiangning Hosp, Nanjing 211100, Peoples R China
2 shared publicationsMengcheng Hu
Nanjing Med Univ, Dept Gastroenterol, Affiliated Jiangning Hosp, Nanjing 211100, Peoples R China
2 shared publications- Feifei Chen
Institute of Oncology, Xuzhou Medical University, Xuzhou, China
1 shared publication - Jian Zhang
Department of Oncology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
1 shared publication Junshi Wang
School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China
1 shared publication
Latest Publications
- 17 June 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (9) , 343
MSFFEC-Net: enhanced polyp segmentation via multi-scale feature fusion with edge-aware enhancement and contrastive learning
- 17 June 2026
- Published by Springer Nature in The Visual Computer
- Vol. 42 (9) , 343
MSFFEC-Net: enhanced polyp segmentation via multi-scale feature fusion with edge-aware enhancement and contrastive learning
- Open Access
MSCB-DualAttn Network for sEMG-Based Gesture Recognition in Transradial Amputees with Varying Residual Limb Lengths
Transradial amputation severely impairs hand function, and myoelectric control offers a promising solution. However, due to the heterogeneity of neuromuscular compensation, existing methods often struggle to generalize across populations with varying residual limb lengths. In this study, we collected an EMG dataset from 41 participants, including healthy individuals and amputees with long, medium, and short residual limbs, performing 15 gestures, and proposed a Multi-Scale Convolutional Block with Dual Attention Network (MSCB-DualAttn) that integrates parallel multi-scale convolutions (kernel sizes 3, 5, and 7) with channel and temporal attention mechanisms. The model achieved recognition accuracies of 93.79%, 86.13%, and 78.10% in the healthy, long-stump, and middle-stump groups, respectively, and 62.69% in the short-stump group, representing a 13.83 percentage point improvement over the baseline model. Ablation studies and interpretability analyses confirmed the complementary roles of the multi-scale and attention modules, while the performance degradation in the short-stump group suggested a potential limitation of existing models when neuromuscular control shifts from fine synergy to coarse compensation. This study proposes a model framework that enhances gesture recognition accuracy in amputees and highlights the potential of physiology-driven architectures for myoelectric control.
Open AccessMSCB-DualAttn Network for sEMG-Based Gesture Recognition in Transradial Amputees with Varying Residual Limb Lengths
Transradial amputation severely impairs hand function, and myoelectric control offers a promising solution. However, due to the heterogeneity of neuromuscular compensation, existing methods often struggle to generalize across populations with varying residual limb lengths. In this study, we collected an EMG dataset from 41 participants, including healthy individuals and amputees with long, medium, and short residual limbs, performing 15 gestures, and proposed a Multi-Scale Convolutional Block with Dual Attention Network (MSCB-DualAttn) that integrates parallel multi-scale convolutions (kernel sizes 3, 5, and 7) with channel and temporal attention mechanisms. The model achieved recognition accuracies of 93.79%, 86.13%, and 78.10% in the healthy, long-stump, and middle-stump groups, respectively, and 62.69% in the short-stump group, representing a 13.83 percentage point improvement over the baseline model. Ablation studies and interpretability analyses confirmed the complementary roles of the multi-scale and attention modules, while the performance degradation in the short-stump group suggested a potential limitation of existing models when neuromuscular control shifts from fine synergy to coarse compensation. This study proposes a model framework that enhances gesture recognition accuracy in amputees and highlights the potential of physiology-driven architectures for myoelectric control.
- Open Access
- 26 July 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 9265088
Establishment and Analysis of a Prognostic Model of Autophagy‐Related lncRNAs in ESCA
Esophageal cancer (ESCA) is a malignant tumor of the upper gastrointestinal tract, with a high mortality rate and poor prognosis. Long noncoding RNAs (lncRNAs) play a role in the malignant progression of tumors by regulating autophagy. This study is aimed at establishing a prognostic model of autophagy‐related lncRNAs in ESCA and provide a theoretical basis to determine potential therapeutic targets for ESCA. The transcriptome expression profiles were downloaded from The Cancer Genome Atlas (TCGA). We identified autophagy‐related mRNAs and lncRNAs in ESCA using differential expression analysis and the Human Autophagy Database (HADb). Four differentially expressed autophagy‐related lncRNAs with a prognostic value were identified using Cox regression and survival analyses. Furthermore, the combination of the selected lncRNAs was able to predict the prognosis of patients with ESCA more accurately than any of the four lncRNAs individually. Finally, we constructed a coexpression network of autophagy‐related mRNAs and lncRNAs. This study showed that autophagy‐related lncRNAs play an important role in the occurrence and development of ESCA and could become a new target for the diagnosis and treatment of this disease.
- 26 July 2022
- Published by Wiley in BioMed Research International
- Vol. 2022 (1) , 9265088
Open AccessEstablishment and Analysis of a Prognostic Model of Autophagy‐Related lncRNAs in ESCA
Esophageal cancer (ESCA) is a malignant tumor of the upper gastrointestinal tract, with a high mortality rate and poor prognosis. Long noncoding RNAs (lncRNAs) play a role in the malignant progression of tumors by regulating autophagy. This study is aimed at establishing a prognostic model of autophagy‐related lncRNAs in ESCA and provide a theoretical basis to determine potential therapeutic targets for ESCA. The transcriptome expression profiles were downloaded from The Cancer Genome Atlas (TCGA). We identified autophagy‐related mRNAs and lncRNAs in ESCA using differential expression analysis and the Human Autophagy Database (HADb). Four differentially expressed autophagy‐related lncRNAs with a prognostic value were identified using Cox regression and survival analyses. Furthermore, the combination of the selected lncRNAs was able to predict the prognosis of patients with ESCA more accurately than any of the four lncRNAs individually. Finally, we constructed a coexpression network of autophagy‐related mRNAs and lncRNAs. This study showed that autophagy‐related lncRNAs play an important role in the occurrence and development of ESCA and could become a new target for the diagnosis and treatment of this disease.
- 1 January 2022
- Vol. 14 (4) , 2331-2342
LINC01272 activates epithelial-mesenchymal transition through miR-153-5p in Crohn's disease
Objectives: Long noncoding RNAs (lncRNAs) have different functions in different diseases. There is little research on the functions of lncRNAs in Crohn's disease (CD). By using RNA-seq technology, we identified a lncRNA associated with Crohn's disease. However, the mechanism of lncRNA regulation remains unknown. This study aimed to determine the association of LINC01272 with epithelial cell-mesenchymal transition and the underlying mechanism in CD. Methods: RNA was detected by qRT-PCR. The interaction of protein and RNA was determined by RNA binding protein immunoprecipitation. Luciferase reporter assays were used to detect the targeted miRNA of LINC01272. Tissue fibrosis was observed by Masson and H&E staining. Protein expression was determined by western blotting and immunofluorescence. Results: LINC01272 was highly expressed in patients with CD. Knockdown of LINC01272 inhibited TGF-01-induced epithelial-mesenchymal transition (EMT). Additionally, LINC01272 regulated TGF-beta 1-induced EMT through the miR-153-5p axis, and knockdown of LINC01272 inhibited EMT in CD mice in vivo. Conclusion: LINC01272 activated the epithelial-mesenchymal transition through miR-153-5p in CD.
- 1 January 2022
- Vol. 14 (4) , 2331-2342
LINC01272 activates epithelial-mesenchymal transition through miR-153-5p in Crohn's disease
Objectives: Long noncoding RNAs (lncRNAs) have different functions in different diseases. There is little research on the functions of lncRNAs in Crohn's disease (CD). By using RNA-seq technology, we identified a lncRNA associated with Crohn's disease. However, the mechanism of lncRNA regulation remains unknown. This study aimed to determine the association of LINC01272 with epithelial cell-mesenchymal transition and the underlying mechanism in CD. Methods: RNA was detected by qRT-PCR. The interaction of protein and RNA was determined by RNA binding protein immunoprecipitation. Luciferase reporter assays were used to detect the targeted miRNA of LINC01272. Tissue fibrosis was observed by Masson and H&E staining. Protein expression was determined by western blotting and immunofluorescence. Results: LINC01272 was highly expressed in patients with CD. Knockdown of LINC01272 inhibited TGF-01-induced epithelial-mesenchymal transition (EMT). Additionally, LINC01272 regulated TGF-beta 1-induced EMT through the miR-153-5p axis, and knockdown of LINC01272 inhibited EMT in CD mice in vivo. Conclusion: LINC01272 activated the epithelial-mesenchymal transition through miR-153-5p in CD.
- Open Access
- 24 August 2021
- Published by Springer Nature in Research Square
LINC01272 Activates Epithelial-Mesenchymal Transition Through miR-153-5p in Crohn’s Disease
Background: Long non-coding RNAs (lncRNAs) have different functions in different diseases. There is seldom research on the functions of lncRNAs in Crohn’s disease (CD). By RNA-seq technology, we identify a lncRNA associated with Crohn's disease. However, the mechanism of lncRNA regulation remains unknown. This study aimed to determine the association of LINC01272 with epithelial cell-mesenchymal transition and the underlined mechanism in CD.Methods: RNA is detected by qRT-PCR. Interaction of protein and RNA was determined by RNA binding protein immunoprecipitation. Luciferase reporter assays were used to detect the targeted miRNA of LINC01272. Tissue fibrosis was observed by Masson and HE staining. The protein expression is determined by western blot and immunofluorescence. Results: LINC01272 was highly expressed in patients with CD. Knockdown of LINC01272 inhibited TGF-β1-induced epithelial-mesenchymal transition (EMT). Additionally, LINC01272 regulated TGF-β1 induced EMT by miR-153-5p axis and knockdown of LINC01272 inhibited EMT in the CD mice in vivo. Conclusion: LINC01272 activated epithelial-mesenchymal transition through miR-153-5p in CD.
- 24 August 2021
- Published by Springer Nature in Research Square
Open AccessLINC01272 Activates Epithelial-Mesenchymal Transition Through miR-153-5p in Crohn’s Disease
Background: Long non-coding RNAs (lncRNAs) have different functions in different diseases. There is seldom research on the functions of lncRNAs in Crohn’s disease (CD). By RNA-seq technology, we identify a lncRNA associated with Crohn's disease. However, the mechanism of lncRNA regulation remains unknown. This study aimed to determine the association of LINC01272 with epithelial cell-mesenchymal transition and the underlined mechanism in CD.Methods: RNA is detected by qRT-PCR. Interaction of protein and RNA was determined by RNA binding protein immunoprecipitation. Luciferase reporter assays were used to detect the targeted miRNA of LINC01272. Tissue fibrosis was observed by Masson and HE staining. The protein expression is determined by western blot and immunofluorescence. Results: LINC01272 was highly expressed in patients with CD. Knockdown of LINC01272 inhibited TGF-β1-induced epithelial-mesenchymal transition (EMT). Additionally, LINC01272 regulated TGF-β1 induced EMT by miR-153-5p axis and knockdown of LINC01272 inhibited EMT in the CD mice in vivo. Conclusion: LINC01272 activated epithelial-mesenchymal transition through miR-153-5p in CD.